Efficacy and Safety of 12-weeks Supplementation of Eubacterium Hallii on Insulin Sensitivity and Glycaemic Control

NCT04529473 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Pre Diabetes
Impaired Glucose Tolerance
Insulin Sensitivity
Insulin Resistance
Glucose Metabolism Disorders
Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT: Eubacterium hallii
OTHER: Placebo

Sponsor

Atlantia Food Clinical Trials

Collaborators

[object Object]